APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
about
Endophenotypes in normal brain morphology and Alzheimer's disease: a reviewRole of walnuts in maintaining brain health with ageDifferential contributions of ApoE4 and female sex to BACE1 activity and expression mediate Aβ deposition and learning and memory in mouse models of Alzheimer's diseaseApolipoprotein E and Alzheimer disease: risk, mechanisms and therapyReduced hippocampal volume in healthy young ApoE4 carriers: an MRI studyGenotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memoryIndependent component analysis of Alzheimer's DNA microarray gene expression dataPlasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status.Use of genetic variation as biomarkers for Alzheimer's disease.Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of eldersSurvival in Alzheimer disease: a multiethnic, population-based study of incident casesUse of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.Effects of hypoperfusion in Alzheimer's disease.Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.Review of cerebral microangiopathy and Alzheimer's disease: relation between white matter hyperintensities and microbleeds.White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machines.KIBRA gene polymorphism has no association with verbal or visual episodic memory performance.Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data SetReduced neuronal signaling in the ageing apolipoprotein-E4 targeted replacement female mice.Physical activity and Alzheimer disease course.Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.The role of apolipoprotein E in Alzheimer's disease.Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.The FAS gene, brain volume, and disease progression in Alzheimer's diseaseProgression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression studyContribution of vascular risk factors to the progression in Alzheimer diseaseAPOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory studySingle neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.Use and cost of hospitalization in dementia: longitudinal results from a community-based studyAPOEε2 is associated with milder clinical and pathological Alzheimer disease.Intracranial volume and dementia: some evidence in support of the cerebral reserve hypothesis.Hearing Loss is Associated With Risk of Alzheimer's Disease: A Case-Control Study in Older People.Genetic Risk Score Predicts Late-Life Cognitive Impairment.The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's DiseaseMedicare Utilization and Expenditures Around Incident Dementia in a Multiethnic Cohort.
P2860
Q24655973-15A1247F-E24A-488E-8C9B-82C8E7A3530FQ27021386-3FE37EBA-D852-4DA7-A442-8196B16F3629Q27323892-0255868D-3D48-4FE9-9133-C004F3571A1CQ28282855-17ECC661-F2E7-43F2-835B-5B94E8CBA4EDQ28390837-71438858-F70C-48D9-886A-677843D8FBB8Q30513966-29790C54-0C97-4C35-A47D-891A6ECC150EQ33403405-C8D5AFCA-A1E5-46E9-8BA2-9ADBEEA4853BQ33609644-54E4981D-FEF6-4580-A7B4-9EE4E9FC3EDAQ33638836-84FFF0D7-8F3C-4B8E-81B1-F80644FBEF03Q33640956-2C7E4C9A-5109-44A9-9894-386C355B554AQ33699266-9DD566F7-716F-402B-80D5-D8712026F6BCQ33745430-EF21263F-F94C-4544-8484-70FCBB0F958DQ34013606-99B0BE98-1A47-4FA9-80B3-AA418064A917Q34039966-0E1B6B75-E3F3-4F90-BE80-05689C1B8ACDQ34055011-415363A5-FE45-4D02-9D79-4CA2F1172878Q34149357-51543E62-BD2D-4935-9B98-2DAD9AF48BD1Q34257037-201C6269-55E2-480F-A27B-2ECF45FABD6AQ34305162-671DAE84-E7F5-438B-ACB3-4F29F579F378Q34311058-9B731D65-EA10-471C-8E0A-8799265868D3Q34317977-60AC273A-63BE-4C92-A7E9-18D1CF9EDC7DQ34388322-7E20CB8C-6390-4884-817C-219F6636FA0DQ34451903-45D6EE8A-1662-4890-9276-4FFDC661820BQ34603092-B44E0635-9407-468A-8AE2-5374074A57A4Q34606568-732BF5D7-BC63-438F-82B2-47D1741ED8F1Q34637899-7A9D37AA-1FB8-4180-B12C-6850B49B41C1Q34766236-2F382B99-198B-4F2B-B677-69F5731A2C40Q34797000-5BA88888-4F96-44C2-9FA4-F3AD7B5BC542Q35001983-C6FE287F-9E83-4379-815A-CEADE9094661Q35004787-5FBF666F-8BD4-45F0-AE5F-F9C105B0529EQ35017596-F954FE71-BA1C-46D2-A456-A04B90F8E965Q35337169-3FF2F47B-B196-4197-8095-471F9BCE58FEQ35523678-0777B3C6-5A9D-4223-A3C1-9AA97802B8E1Q35525317-03CC0EC6-E35B-4B84-969C-AF1688017841Q35554635-A3776720-846B-47BE-9FD9-DF47F3A9635DQ35660968-735E5D75-7490-46D0-9043-E0DCE5D7C5A2Q35697954-593D23E8-1F95-41C1-A7A9-4C0803D1D4D4Q35897531-A0304ECC-BCF3-4D57-B1F8-DB2EFB8E1DD9Q36031233-BDF01F3C-48A1-4E35-A84D-D3E2BAD9C11CQ36075642-6DADA64D-2A0B-45F8-B324-A9FB31F62426Q36181521-34A9534B-846A-4C3B-BE43-741C6EBAF0F2
P2860
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
@en
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.
@nl
type
label
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
@en
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.
@nl
prefLabel
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
@en
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.
@nl
P2093
P2860
P1433
P1476
APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease
@en
P2093
P2860
P304
P356
10.1212/01.WNL.0000304038.37421.CC
P407
P433
P577
2008-04-09T00:00:00Z